ArticleAmerican journal of physiology. Heart and circulatory physiology2025
Comparative analysis of isoproterenol- and lipopolysaccharide-mediated cytoprotective responses in the heart.
Article in American journal of physiology. Heart and circulatory physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cardiac tertiary immune niches drive immune activation in immune checkpoint inhibitor myocarditis.Science advances · 2026Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
Abstract
A panoply of different stimuli activates endogenous signaling pathways that confer cardioprotection in the heart; however, it is unclear whether these stimuli engage similar or distinct biological pathways. We showed that tissue injury induced by isoproterenol (ISO), or pretreatment with the Toll-like receptor 4 agonist lipopolysaccharide (LPS), protects the heart against the myopathic effects of a subsequent exposure to ISO. Here, we used a multiomic approach to examine ISO- and LPS-treated hearts to identify shared and distinct biological themes. Bulk RNA sequencing showed that ISO and LPS elicited upregulation of distinct stress response signatures that featured interferon (IFN) signaling, while converging on the widespread downregulation of pathways related to metabolism or cell growth. Multiome (RNA + ATAC) sequencing revealed that ISO-treated hearts underwent distinct chromatin remodeling, with more regions showing decreased accessibility than increased accessibility. IFN-related pathways were consistently enriched across many cell types in the heart, including endocardial cells, TNK cells, myeloid cells, and endothelial cells. Analysis of cell-cell interactions using CellChat showed that ISO stimulation enhanced communication between myeloid cells with fibroblasts, TNK cells, and pericytes. Remarkably, cell-cell interactions for cardiac myocytes were restricted to myeloid cells. Bulk ATAC sequencing of bone marrow-derived hematopoietic stem and progenitor cells (HSPCs) demonstrated that ISO and LPS stimulation predominantly resulted in decreased chromatin accessibility in HSPCs and bone marrow stromal cells. Viewed together, these studies show that although ISO and LPS engage distinct upstream signaling pathways, both converge on IFN signaling and a shared suppression of energy-intensive pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.